UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway

Annals of oncology, 2010-02, Vol.21 (2), p.263-268

2010

Volltextzugriff (PDF)

Detection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs

Annals of oncology, 2019-04, Vol.30, p.ii52-ii52

2019

Volltextzugriff (PDF)

137PDetection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma

Annals of oncology, 2013-08, Vol.24 (8), p.2131-2136

2013

Volltextzugriff (PDF)

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Annals of oncology, 2014-12, Vol.25 (12), p.2385-2391

2014

Volltextzugriff (PDF)

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma

Annals of oncology, 2013-04, Vol.24 (4), p.1055-1061

2013

Volltextzugriff (PDF)

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial

Annals of oncology, 2023-02, Vol.34 (2), p.163-172

2023

Volltextzugriff (PDF)

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Annals of oncology, 2019-03, Vol.30 (3), p.397-404

2019

Volltextzugriff (PDF)

Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies

Annals of oncology, 2023-05, Vol.34 (5), p.486-495

2023

Volltextzugriff (PDF)

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Annals of oncology, 2017-10, Vol.28 (10), p.2443

2017

Volltextzugriff (PDF)

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Annals of oncology, 2021-01, Vol.32 (1), p.85-96

2021

Volltextzugriff (PDF)

Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial

Annals of oncology, 2017-04, Vol.28 (4), p.777-783

2017

Volltextzugriff (PDF)

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

Annals of oncology, 2022-05, Vol.33 (5), p.500-510

2022

Volltextzugriff (PDF)

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Annals of oncology, 2019-04, Vol.30 (4), p.582-588

2019

Volltextzugriff (PDF)

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Annals of oncology, 2015-08, Vol.26 (8), p.1766-1771

2015

Volltextzugriff (PDF)

Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

Annals of oncology, 2017-09, Vol.28 (9), p.2199-2205

2017

Volltextzugriff (PDF)

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients

Annals of oncology, 2013-07, Vol.24 (7), p.1786-1792

2013

Volltextzugriff (PDF)

Clinicopathological features of ALK protein in 9889 non-small-cell lung cancer specimens and genomic rearrangement identified by capture-based next-generation sequencing: A Chinese retrospective analysis

Annals of oncology, 2018-11, Vol.29, p.ix147-ix147

2018

Volltextzugriff (PDF)

1584P Conversion effect of PD-1 antibody camrelizumab (Cam) combined with modified FLOT (mFLOT) regimen in patients(pts) with initially unresectable locally advanced or limited metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Annals of oncology, 2023-10, Vol.34, p.S882-S882

2023

Volltextzugriff (PDF)

Education and lung cancer: A Mendelian randomisation study

Annals of oncology, 2019-04, Vol.30, p.ii18-ii18

2019

Volltextzugriff (PDF)

Nomogram for patients with stage I small cell lung cancer: A competing risk analysis

Annals of oncology, 2019-04, Vol.30, p.ii22-ii22

2019

Volltextzugriff (PDF)

A Mendelian randomization study of the effects of Crohn’s disease on lung cancer

Annals of oncology, 2019-04, Vol.30, p.ii18-ii18

2019

Volltextzugriff (PDF)

1242MO The addition of belomethason propionate inhalation to radical radiotherapy for patients with locally advanced non-small cell lung cancer: A randomized controlled, open-label phase II study

Annals of oncology, 2024-09, Vol.35, p.S795-S795

2024

Volltextzugriff (PDF)

181P TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study

Annals of oncology, 2023-11, Vol.34, p.S1545

2023

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnnals Of Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(213)

Publikationsform

Artikel
(213)

Sprache

Englisch
(213)

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(28)
Oncology
(28)
Science & Technology
(28)
Female
(18)
Male
(15)
Middle Aged
(15)
Adult
(12)
Antineoplastic Agents
(12)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Pharmacology. Drug Treatments
(12)
Aged
(11)
Tumors
(11)
Aged, 80 And Over
(6)
Multiple Tumors. Solid Tumors. Tumors In Childhood
(6)
Mutation
(6)
Prospective Studies
(6)
Young Adult
(6)
Biomarkers, Tumor - Genetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(26)

Menü

Weitere Dienste

Einstellungen

Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway

Detection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs

137PDetection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs

Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial

Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients

Clinicopathological features of ALK protein in 9889 non-small-cell lung cancer specimens and genomic rearrangement identified by capture-based next-generation sequencing: A Chinese retrospective analysis

1584P Conversion effect of PD-1 antibody camrelizumab (Cam) combined with modified FLOT (mFLOT) regimen in patients(pts) with initially unresectable locally advanced or limited metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Education and lung cancer: A Mendelian randomisation study

Nomogram for patients with stage I small cell lung cancer: A competing risk analysis

A Mendelian randomization study of the effects of Crohn’s disease on lung cancer

1242MO The addition of belomethason propionate inhalation to radical radiotherapy for patients with locally advanced non-small cell lung cancer: A randomized controlled, open-label phase II study

181P TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study

Aktive Filter

Suchergebnisse filtern